OSIR

Osiris Therapeutics, Inc. News Headlines

$14.72
*  
0.20
1.38%
Get OSIR Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading OSIR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Jason Napodano Positions For 2014: Biotech M&A Growth Trend To Continue
12/31/2013 10:45:00 AM - Seeking Alpha

Idenix Pharmaceuticals (IDIX) Soars: Stock Adds 18.2% in Session - Tale of the Tape
12/26/2013 10:11:01 AM - Zacks.com

Zacks #1 Rank Additions for Wednesday - Tale of the Tape
11/27/2013 10:07:10 AM - Zacks.com

Peregrine Pharmaceuticals (PPHM) Jumps: Stock Rises 6.2% - Tale of the Tape
11/22/2013 10:06:48 AM - Zacks.com

Medivation Q3 Loss Narrower Than Expected - Analyst Blog
11/13/2013 10:06:20 AM - Zacks.com

AstraZeneca to Invest in New Zoladex Facility - Analyst Blog
11/12/2013 1:05:43 PM - Zacks.com

AVEO Q3 Loss Wider than Expected, Shares Down - Analyst Blog
11/12/2013 10:05:12 AM - Zacks.com

Jazz Pharma Upgraded to Strong Buy - Analyst Blog
11/11/2013 6:00:01 PM - Zacks.com

Geron Q3 Loss in Line; Shares Up on ASH Abstract - Analyst Blog
11/11/2013 11:00:01 AM - Zacks.com

Osiris Up on Q3 Earnings - Analyst Blog
11/5/2013 10:00:01 AM - Zacks.com

Mid-Afternoon Market Update: JC Penney Falls on Massive Volume Following Imperial Capital Price Target
10/21/2013 3:29:38 PM - Benzinga

Mid-Day Market Update: Hasbro Surges On Upbeat Earnings; Gannett Shares Tumble
10/21/2013 12:51:57 PM - Benzinga

Mid-Morning Market Update: Markets Mixed; McDonald's Posts Higher Q3 Profit
10/21/2013 10:26:03 AM - Benzinga

Osiris Shares Continue to Gain - Analyst Blog
10/15/2013 11:30:01 AM - Zacks.com

Mesoblast: Prochymal Deal Controversy Creates Buying Opportunity
10/15/2013 10:52:00 AM - Seeking Alpha

Pluristem's Promising GvHD Indication Pits It Against Osiris
10/7/2013 5:52:00 PM - Seeking Alpha

Sector Update: Biotech Stocks Helping The NASDAQ
10/2/2013 2:37:11 PM - MT Newswires

Celgene's And Osiris' IP Positions Weakened By Pluristem's Pivotal Patent
9/12/2013 8:20:00 AM - Seeking Alpha

U.S.: Half-Empty Or Half-Full? Investing In Guns And Gold Vs. Biotech
9/4/2013 5:41:00 PM - Seeking Alpha

3 Biotech Products To Watch Over The Next Year
9/4/2013 10:03:00 AM - Seeking Alpha

Sanuwave May Be Able To Satisfy Investor Appetite For A Diabetic Foot Ulcer Treatment
8/18/2013 1:51:00 PM - Seeking Alpha

SA Pro: Top Long And Short Ideas, Friday August 16
8/17/2013 7:45:00 AM - Seeking Alpha

SA Pro: Top Long And Short Ideas, Thursday August 15
8/16/2013 7:45:00 AM - Seeking Alpha

Osiris Up on Grafix Data - Analyst Blog
8/14/2013 4:30:43 PM - Zacks.com

Athersys: Extreme Undervaluation Poses An Opportunity
8/14/2013 3:13:00 PM - Seeking Alpha